Propolis is an antimicrobial agent whose composition can vary depending on the area from which it is collected. The aim of this study was to determine the in vitro activity of two propolis samples from northern and southern Iran (Mazandaran and Hormozgan province respectively) against some fluconazole-resistant Candida albicans strains isolated from HIV + patients with oropharyngeal candidiasis (OPC). The chemical composition of propolis samples was determined by high-resolution gas chromatography coupled to mass spectrometry (GC-MS). Ethanolic extracts were prepared from the propolis samples. The minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) of propolis on the growth of C. albicans isolates were determined using the broth microdilution method. The main compounds of propolis extracts were aromatic acids such as caffeic acid (1.6% for northern and 2.2% for southern samples). The propolis extracts showed antifungal activities; the concentrations capable of inhibiting all of the yeasts ranged from 2 to 20 mg/mL. Propolis from southern Iran showed the most effective MIC values for the yeasts studied. Because of increased antifungal resistance, propolis may be kept in mind in the treatment of oral cavity diseases such as OPC in HIV + patients.
Introduction
The oral cavity is inhabited by more than 700 microbial species and many intrinsic and extrinsic factors affect the composition, metabolic activity and pathogenicity of the highly diversified oral microflora (Aas et al., 2005) . Over the past decades, there has been a significant increase in the prevalence of fungal infections caused by Candida species. This fact has been correlated mainly to the use of broad-spectrum antifungals, corticosteroids, anti-tumoral agents, oral contraceptives and an increase in the number of immunocompromised patients (Eggimann et al., 2003) . In HIV + patients, Candida is cited as an important cause of mortality and morbidity (Coleman et al., 1998) . OPC occurs in more than 95% of HIV + patients and it is considered as an important marker of the disease and its progression. The prevalence of OPC in HIV + patients seems to be correlated to the severity of immunological dysfunction (Al-Abeid et al., 2004) . The occurrence of OPC at initial stages of AIDS is common, particularly when CD 4 + cell count is low (400-700 cells/mm 3 ) (Lin et al., 2001 ).
In recent years, drug-resistance to antifungal agents and optimizing therapy of Candida infections have been broadly focused (Lai et al., 2008) . Moreover, the therapeutic arsenal available for the treatment of fungal infections is quite restricted, being limited to polyenic and azolic antifungal agents (Espinel-Ingroff and Canton, 2008) . Of azolics, fluconazole (FLU) is one of the most common agent used in OPC and the development of resistance of C. albicans and non-C. albicans yeasts against this drug has been reported (Sobel, 2007) . These facts make it difficult to manage patients with OPC and put into evidence the need of searching for new, effective, safe, low-cost antifungal alternatives against this pathology.
Natural products have been traditionally used in the treatment of diseases because they are sources of many active compounds.
Propolis, a strongly adhesive resinous compound produced by Apis mellifera L. bees, has demonstrated important antimicrobial and immunostimulatory activities and has been used to treat inflammatory, bacterial, viral and fungal diseases (Miyataka et al., 1997; Kujumgiev et al., 1999; Velikova et al., 2000; Murad et al., 2002 
Materials and methods

Propolis samples
The propolis samples were collected from hives of Apis mellifera L.
bees of northern (Mazandaran province) and southern Iran (Hormozgan province). Each sample was combined into a single batch, packed in a sealed plastic bag and stored at -20ºC.
Preparation of ethanolic extract
The propolis extracts were prepared as a 25% (w/v) concentration with absolute ethyl alcohol. The extracts were placed in amber flasks, tightly sealed and stored at room temperature.
GC-MS analysis
The ethanolic extracts were filtered through Whatman No. 1 filter papers and freeze-dried. The dry residual powders were kept at -20ºC. About 5 mg of residue were mixed with 75 μL of dry pyridine and 50 μL bis (trimethylsilyl) trifluoroacetamide (BSTFA), heated at 80ºC for 20 min and then the final supernatant was analyzed by GC-MS method (Sorkun et al., 2001) . Briefly, the GC-MS analysis was performed by temperature programming. The column oven temperature was initially held at 100ºC for 2 min, then programmed to rise to 280ºC at a rate of 20ºC /min and held for 5 min. The total run-time was 16 min. The temperatures of the injector port and the interface were set at 250 and 280ºC, respectively. The carrier gas (helium) flow rate was 1.0 mL/min. The ionization energy was set at 70 eV. The mass spectra were collected by scanning from m/z 50 to m/z 550 at two second intervals. The identification of various compounds present in propolis samples was carried out by computer search on MS database libraries on the basis of mass spectral fragmentation. The available reference compounds were cochromatographed to confirm GC retention times. Some compounds could not be identified due to the lack of authentic samples and their library spectra.
Chemicals
One kind of synthetic product was used in this study (Fluconzole - 
Antifungal assays
The yeast isolates were tested by the Clinical Laboratory Standards
Institute reference broth microdilution method for FLU (CLSI, 2002) and with modifications for propolis samples (NCCLS, 1997) . Stock Data were analyzed by using the t-student test with 95% confidence limit. A P value less than 0.05 was statistically considered as significant.
Result
The chemical composition of ethanolic extracts of the propolis samples, before the determination of MICs and MFCs of propolis collected from northern (Mazandaran province) and southern (Hormozgan province) Iran were determind using the GC-MS system and calculated from the peak area of target compounds and the sum of peak areas as a percent in the chromatogram of propolis samples. 
Discussion
Propolis samples vary within a given area, the time of collection, amount of wax contents and the diverse plant origins of propolis (Marcucci, 1995) . This could possibly explain why many authors have given different results of MIC and MFC profiles in their reports. In the present study, although the propolis samples did not differ significantly in their activities against test microorganisms, the southern propolis sample showed higher activity than the northern one. This may be due to the high contents of total aliphatic and why propolis is suggested to be used in the stomatological field for its antimicrobial and anti-inflammatory properties as well as for its analgesic qualities (Ceschel et al., 2002) .
The prolonged use of antifungal agents has provoked problems concerning the increasing public importance in relation to the contamination of perishables with fungicidal residues and growing resistance in the pathogen populations (Marco et al., 1998) .
OPC is the most frequent fungal infection in HIV + patients (95%), especially in advanced HIV infections (Al-Abeid et al., 2004) .
Interestingly, among the patients with OPC who had a history of antifungal therapy such as FLU, it seems that secondary resistance occurred during last antifungal therapy in these patients (Hoepelman and Dupont, 1996) . Regarding the increasing resistance and therapeutic failure of OPC infection in recent years, we therefore investigated the anti-C. albicans activity of the propolis product.
In conclusion, the propolis extracts showed excellent effects against resistant C. albicans identified as OPC agents. This activity is not only fungistatic but also fungicidal, even in small concentrations.
The results reinforce the importance and the potential of propolis extract as a treatment for OPC.
